Firefly Neuroscience, Inc.

Firefly Neuroscience, Inc. is an artificial intelligence company that develops, markets, and distributes medical devices and technologies for high-resolution visualization and evaluation of the brain's complex neurophysiological interconnections in North America. Its Evoke System performs electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by a cloud-based platform and returned as structured reports to support clinical decision-making for conditions such as depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury. The company serves clinicians and was founded in 2006, with headquarters in Kenmore, New York.